Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
Agility Robotic's legged locomotion expertise is built on a history of academic research, including the bipedal walking and running robot ATRIAS. Agility Robotics is leveraging this work to create products that address the real world needs of rugged, efficient, and highly capable mobility platforms.
Alation pioneered the data catalog market and today is leading its evolution into a platform for a broad range of data intelligence solutions including data search & discovery, data governance, data stewardship, analytics, and digital transformation. Thanks to its powerful Behavioral Analysis Engine, inbuilt collaboration capabilities, and open interfaces, Alation combines machine learning with human insight to successfully tackle even the most demanding challenges in data and metadata management. More than 240 enterprises drive data culture, improve decision making, and realize business outcomes with Alation including AbbVie, American Family Insurance, Cisco, Exelon, Finnair, Munich Re, New Balance, Pfizer, Scandinavian Airlines, and US Foods. Headquartered in Silicon Valley, Alation is backed by leading venture capitalists including Costanoa, Data Collective, Icon, Sapphire, and Salesforce Ventures.
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.
Brimstone is on a mission to decarbonize the cement industry. The $1 trillion cement market is responsible for 7.5% of carbon emissions annually, with a greenhouse gas impact just behind cars. Founded in 2019, Brimstone developed a breakthrough carbon-negative process to produce the same ordinary portland cement and supplementary cementitious materials used today. These materials have the same quality and performance builders have trusted for over 150 years — now with a positive climate impact.
Capella Space is an information services company that provides sub 0.5m very high-resolution synthetic aperture radar earth observation imagery. Through a constellation of small satellites, Capella is providing easy access to frequent, timely, and flexible information affecting dozens of industries worldwide. Capella’s high-resolution SAR satellites are matched with unparalleled infrastructure to deliver reliable global insights that sharpen the understanding of the changing world, improving decisions about commerce, conservation, and well-being on Earth. The company aims to make timely Earth observation an essential tool for commerce, conservation, and well-being. Capella Space was founded in 2014 and based in San Francisco, California.
Carbon Health is a tech-enabled healthcare company that delivers virtual care experience. It offers primary care services through a mobile application that enables users to follow-up on a treatment plan, manage prescriptions, and see lab reports all through one app. Carbon Health has created a coronavirus assessment tool and also set up covid-19 testing in California. The company was founded in 2015 and is headquartered in San Francisco, California.
